S&P 500   4,284.52 (-0.08%)
DOW   33,390.48 (-0.35%)
QQQ   359.98 (+0.48%)
AAPL   172.87 (+0.97%)
MSFT   317.32 (+0.50%)
META   304.51 (+1.43%)
GOOGL   133.24 (+1.82%)
AMZN   129.10 (+1.56%)
TSLA   250.44 (+0.09%)
NVDA   448.50 (+3.11%)
NIO   8.77 (-2.99%)
BABA   86.20 (-0.62%)
AMD   102.20 (-0.60%)
T   14.82 (-1.33%)
F   12.27 (-1.21%)
MU   67.52 (-0.75%)
CGC   0.78 (-0.37%)
GE   109.28 (-1.15%)
DIS   80.89 (-0.20%)
AMC   7.86 (-1.63%)
PFE   33.33 (+0.48%)
PYPL   58.66 (+0.34%)
NFLX   380.30 (+0.72%)
S&P 500   4,284.52 (-0.08%)
DOW   33,390.48 (-0.35%)
QQQ   359.98 (+0.48%)
AAPL   172.87 (+0.97%)
MSFT   317.32 (+0.50%)
META   304.51 (+1.43%)
GOOGL   133.24 (+1.82%)
AMZN   129.10 (+1.56%)
TSLA   250.44 (+0.09%)
NVDA   448.50 (+3.11%)
NIO   8.77 (-2.99%)
BABA   86.20 (-0.62%)
AMD   102.20 (-0.60%)
T   14.82 (-1.33%)
F   12.27 (-1.21%)
MU   67.52 (-0.75%)
CGC   0.78 (-0.37%)
GE   109.28 (-1.15%)
DIS   80.89 (-0.20%)
AMC   7.86 (-1.63%)
PFE   33.33 (+0.48%)
PYPL   58.66 (+0.34%)
NFLX   380.30 (+0.72%)
S&P 500   4,284.52 (-0.08%)
DOW   33,390.48 (-0.35%)
QQQ   359.98 (+0.48%)
AAPL   172.87 (+0.97%)
MSFT   317.32 (+0.50%)
META   304.51 (+1.43%)
GOOGL   133.24 (+1.82%)
AMZN   129.10 (+1.56%)
TSLA   250.44 (+0.09%)
NVDA   448.50 (+3.11%)
NIO   8.77 (-2.99%)
BABA   86.20 (-0.62%)
AMD   102.20 (-0.60%)
T   14.82 (-1.33%)
F   12.27 (-1.21%)
MU   67.52 (-0.75%)
CGC   0.78 (-0.37%)
GE   109.28 (-1.15%)
DIS   80.89 (-0.20%)
AMC   7.86 (-1.63%)
PFE   33.33 (+0.48%)
PYPL   58.66 (+0.34%)
NFLX   380.30 (+0.72%)
S&P 500   4,284.52 (-0.08%)
DOW   33,390.48 (-0.35%)
QQQ   359.98 (+0.48%)
AAPL   172.87 (+0.97%)
MSFT   317.32 (+0.50%)
META   304.51 (+1.43%)
GOOGL   133.24 (+1.82%)
AMZN   129.10 (+1.56%)
TSLA   250.44 (+0.09%)
NVDA   448.50 (+3.11%)
NIO   8.77 (-2.99%)
BABA   86.20 (-0.62%)
AMD   102.20 (-0.60%)
T   14.82 (-1.33%)
F   12.27 (-1.21%)
MU   67.52 (-0.75%)
CGC   0.78 (-0.37%)
GE   109.28 (-1.15%)
DIS   80.89 (-0.20%)
AMC   7.86 (-1.63%)
PFE   33.33 (+0.48%)
PYPL   58.66 (+0.34%)
NFLX   380.30 (+0.72%)
NASDAQ:IXHL

Incannex Healthcare (IXHL) News Today

$1.19
+0.05 (+4.70%)
(As of 09:56 AM ET)
Compare
Today's Range
$1.19
▼
$1.19
50-Day Range
$1.11
▼
$1.94
52-Week Range
$1.03
▼
$4.87
Volume
226 shs
Average Volume
47,288 shs
Market Capitalization
$75.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
finance.yahoo.com logoIncannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023
finance.yahoo.com - September 8 at 9:58 AM
msn.com logoIncannex to file for US testing of psychedelic drug for anxiety
msn.com - August 24 at 10:05 PM
finance.yahoo.com logoIncannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD
finance.yahoo.com - August 24 at 12:04 PM
proactiveinvestors.com.au logoIncannex preparing psilocybin therapy FDA IND application
proactiveinvestors.com.au - August 24 at 12:38 AM
benzinga.com logoFDA Approves Clinical Trial Of Incannex's Dronabinol-Based Drug For Obstructive Sleep Apnea
benzinga.com - August 22 at 9:50 AM
proactiveinvestors.com logoIncannex Healthcare’s Clarion Clinics accepting registrations for psychedelic-assisted therapy treatment
proactiveinvestors.com - August 8 at 8:09 AM
finance.yahoo.com logoClarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
finance.yahoo.com - August 8 at 8:09 AM
au.investing.com logoIncannex Healthcare connects superannuation shareholders with independent advice amid US redomiciliation
au.investing.com - August 1 at 1:56 AM
finanznachrichten.de logoIncannex Healthcare: Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
finanznachrichten.de - July 27 at 1:29 AM
benzinga.com logoIncannex Completes Positive Pre-IND Meeting With FDA On CBD-Based Drug For Treatment Of Rheumatoid Arthritis
benzinga.com - July 27 at 1:29 AM
finance.yahoo.com logoIncannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
finance.yahoo.com - July 27 at 1:29 AM
msn.com logoIncannex submits IND to begin testing of cannabinoid sleep apnea drug
msn.com - July 21 at 12:58 PM
benzinga.com logoIncannex Submits IND Application To The FDA For Dronabinol-Based Drug For Obstructive Sleep Apnea
benzinga.com - July 21 at 12:58 PM
proactiveinvestors.com.au logoIncannex Healthcare targeting clinical trial for sleep apnoea treatment following milestone FDA meeting
proactiveinvestors.com.au - July 20 at 8:07 PM
benzinga.com logoFortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea
benzinga.com - July 18 at 12:01 PM
msn.com logoIncannex plans to redomicile to US with sole NASDAQ listing – we look at the arithmetic
msn.com - July 11 at 10:36 PM
finance.yahoo.com logoIncannex CEO talks plans to redomicile to US
finance.yahoo.com - July 11 at 5:36 PM
seekingalpha.com logoIncannex Healthcare to redomicile from Australia to US, list on Nasdaq
seekingalpha.com - July 10 at 3:42 PM
proactiveinvestors.com logoIncannex Healthcare gets ethics green light to proceed with trial of asset targeting obstructive sleep apnoea
proactiveinvestors.com - July 5 at 8:29 PM
finance.yahoo.com logoIncannex Appoints Principal Investigators for IHL-42X Phase 2/3 Clinical Trial
finance.yahoo.com - June 16 at 8:52 AM
marketbeat.com logoResearch Analysts Set Expectations for Incannex Healthcare Limited's FY2023 Earnings (NASDAQ:IXHL)
marketbeat.com - June 5 at 1:44 AM
proactiveinvestors.com logoIncannex welcomes world-leading psychedelics experts to advisory board
proactiveinvestors.com - June 1 at 2:14 AM
finance.yahoo.com logoWorld Renowned International Psychedelics Experts Join Clarion Clinics Advisory Board
finance.yahoo.com - May 30 at 8:34 AM
msn.com logoPsychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary
msn.com - May 16 at 6:32 PM
finance.yahoo.com logoIncannex Company Presentation – Presentation of Psychennex, Psychedelic Therapies Subsidiary Company
finance.yahoo.com - May 16 at 8:31 AM
finance.yahoo.com logoIncannex enters a lease for first psychedelic-assisted psychotherapy clinic
finance.yahoo.com - May 5 at 7:53 AM
finance.yahoo.com logoIncannex Company Presentation – Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
finance.yahoo.com - May 3 at 9:00 AM
usnews.com logoHealth Care Access
usnews.com - May 2 at 8:21 PM
msn.com logoPsyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
msn.com - May 1 at 11:45 PM
proactiveinvestors.com logoIncannex announces final results from Phase 1 Clinical Trial assessing safety and pharmacokinetics of IHL-675A
proactiveinvestors.com - May 1 at 11:45 PM
msn.com logoNew Clinical MDMA And Psilocybin Batches Head To Flourishing Psychedelics Market
msn.com - April 25 at 6:07 PM
finance.yahoo.com logoPharmAla Biotech to supply Incannex with GMP LaNeo MDMA and Psilocybin
finance.yahoo.com - April 25 at 8:06 AM
proactiveinvestors.com logoIncannex Healthcare appoints QPS to advance nicotine and opioid addiction treatment and Renecann™ products in the US and EU
proactiveinvestors.com - April 14 at 12:06 AM
benzinga.com logoIncannex Healthcare Prepares To Launch Psychedelics Clinics Via New Subsidiary
benzinga.com - March 17 at 11:45 AM
finance.yahoo.com logoIncannex to Commercialise its Psychedelic Clinics Business in Collaborative Partnership with Leading Psychedelic Experts
finance.yahoo.com - March 16 at 12:32 PM
benzinga.com logoPsychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
benzinga.com - March 15 at 9:18 PM
proactiveinvestors.com logoIncannex Healthcare to cut the ribbon on its first psychedelic-assisted psychotherapy clinic in 2023
proactiveinvestors.com - March 15 at 9:18 PM
finance.yahoo.com logoWhy Incannex Healthcare Shares Are Gaining Today
finance.yahoo.com - March 15 at 4:18 PM
finance.yahoo.com logoInterim review of proprietary PsiGAD clinical trial data indicates no safety concerns and projects a statistically significant benefit for the psilocybin arm versus the placebo arm in those participants who have completed the treatment
finance.yahoo.com - March 15 at 8:58 AM
proactiveinvestors.com logoIncannex Healthcare interim review of PsiGAD therapy reveals 85% probability of significant benefit to patients
proactiveinvestors.com - March 14 at 10:51 PM
marketbeat.com logo
marketbeat.com - March 10 at 6:02 AM
finance.yahoo.com logoIncannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use
finance.yahoo.com - March 3 at 12:04 PM
benzinga.com logoIncannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
benzinga.com - March 3 at 10:45 AM
proactiveinvestors.com logoIncannex Healthcare kicks off Phase 2 rheumatoid arthritis trial
proactiveinvestors.com - February 28 at 1:23 AM
proactiveinvestors.com logoIncannex Healthcare has a significant opportunity in anxiety treatment: Edison Investment Research
proactiveinvestors.com - January 19 at 11:29 PM
finance.yahoo.com logoIndependent data review commences for Phase 2 trial of psilocybin-assisted psychotherapy for anxiety
finance.yahoo.com - January 18 at 9:10 AM
marketbeat.com logoShort Interest in Incannex Healthcare Limited (NASDAQ:IXHL) Decreases By 12.1%
marketbeat.com - January 2 at 6:55 AM
proactiveinvestors.com logoIncannex Healthcare has cash runway into CY25 following fund-raise: Edison Investment Research
proactiveinvestors.com - December 8 at 1:42 AM
proactiveinvestors.com logoIncannex Healthcare discusses A$13 million institutional placement
proactiveinvestors.com - December 5 at 9:06 PM
proactiveinvestors.com logoIncannex Healthcare beefs up cash position with A$13 million institutional placement
proactiveinvestors.com - December 4 at 10:40 PM
Get Incannex Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter.



IXHL Media Mentions By Week

IXHL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IXHL
News Sentiment
▼
1.43

0.69
▲
Average
Medical
News Sentiment

IXHL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IXHL Articles
This Week
▼
2

1
▲
IXHL Articles
Average Week

Get Incannex Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:IXHL) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -